101
|
Ius F, Sommer W, Poyanmehr R, Tudorache I, Kuehn C, Avsar M, Siemeni T, Salman J, Molitoris U, Greer M, Verboom M, Boethig D, Schwerk N, Welte T, Haverich A, Warnecke G, Gottlieb J. Risk Factors and Impact of Bronchial Stenoses after Lung Transplantation: Ten Year Single Center Experience with over 1,100 Patients. J Heart Lung Transplant 2016. [DOI: 10.1016/j.healun.2016.01.374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
102
|
Ius F, Sommer W, Verboom M, Erdfelder C, Tudorache I, Kuehn C, Avsar M, Salman J, Siemeni T, Molitoris U, Greer M, Blasczyk R, Hallensleben M, Schwerk N, Welte T, Haverich A, Gottlieb J, Warnecke G. IgM Enriched Human Immunoglobulins and Rituximab Nullify the Mortality Risk Associated with Early Donor Specific Antibodies After Lung Transplantation. J Heart Lung Transplant 2016. [DOI: 10.1016/j.healun.2016.01.471] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
103
|
Dettmer S, Suhling H, Vogel-Claussen J, Westphal M, Haverich A, Welte T, Wacker F, Gottlieb J, Shin H. Veränderungen in der Computertomografie bei chronischer Allograft-Dysfunktion nach Lungentransplantation: Prädiktiver Wert für das weitere Fortschreiten der Erkrankung und das Überleben. ROFO-FORTSCHR RONTG 2016. [DOI: 10.1055/s-0036-1581813] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
104
|
Ewig S, Höffken G, Kern W, Rohde G, Flick H, Krause R, Ott S, Bauer T, Dalhoff K, Gatermann S, Kolditz M, Krüger S, Lorenz J, Pletz M, de Roux A, Schaaf B, Schaberg T, Schütte H, Welte T. Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie und Prävention – Update 2016. Pneumologie 2016; 70:151-200. [DOI: 10.1055/s-0042-101873] [Citation(s) in RCA: 66] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
105
|
Jarosch I, Gehlert S, Jacko D, Koczulla R, Wencker M, Welte T, Bloch W, Janciauskiene S, Kenn K. Pneumologische Rehabilitation bei Patienten mit Alpha-1-Antitrypsin-Mangel: Einfluss der Substitutionstherapie. Pneumologie 2016. [DOI: 10.1055/s-0036-1572139] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
106
|
Behr J, Wirtz H, Prasse A, Pittrow D, Klotsche J, Koschel D, Grohé C, Andreas S, Neurohr C, Claussen M, Wilkens H, Skowasch D, Welte T, Kirschner J, Meyer FJ, Ewert R, Schwaiblmair M, Koch A, Huber RM, Held M, Bahmer T, Gläser S, Herth FJF, Randerath WJ, Kreuter M. Klinischer Verlauf von Patienten mit Idiopathischer Lungenfibrose in der klinischen Praxis: aktuelle Daten aus dem INSIGHTS-IPF Register. Pneumologie 2016. [DOI: 10.1055/s-0036-1572077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
107
|
Hohlfeld J, Biller H, Hagedorn I, Berliner D, Bauersachs J, Welte T, Vogel-Claussen J. Ein neuartiges Studiendesign mit Magnetresonanz-Bildgebungsverfahren zur Untersuchung des Effekts der Indacaterol/Glycopyrronium Fixdosiskombination auf die kardiale Funktion bei COPD Patienten: die CLAIM-Studie. Pneumologie 2016. [DOI: 10.1055/s-0036-1572020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
108
|
Buck A, Rademacher J, Price M, Schwerk N, Welte T, Ringshausen FC. Primäre Ciliäre Dyskinesie im Erwachsenenalter – daran denken und gezielt danach suchen! Pneumologie 2016. [DOI: 10.1055/s-0036-1572138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
109
|
Ringshausen FC, de Roux A, Diel R, Hohmann D, Welte T, Rademacher J. Bronchiektasen in Deutschland: eine Berechnung der Prävalenz aus GKV-Routinedaten. Pneumologie 2016. [DOI: 10.1055/s-0036-1572251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
110
|
Welte T, Salzberger B. Tuberkulose. Internist (Berl) 2016; 57:105-6. [DOI: 10.1007/s00108-015-0015-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
111
|
Knöfel A, Nakagiri T, Ius F, Salman J, Sommer W, Avsar M, Jansson K, Pauksch L, Preissler G, Hatz R, Kühn C, Tudorache I, Welte T, Gottlieb J, Haverich A, Warnecke G. Early Donor Specific Antibodies after Lung Transplantation Correlate with a Distinct Cellular Immune Phenotype in Peripheral Blood. Thorac Cardiovasc Surg 2016. [DOI: 10.1055/s-0036-1571750] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
112
|
Haller H, Manns MP, Welte T. [Transplantation: Opportunities and limits]. Internist (Berl) 2016; 57:5-6. [PMID: 26782279 DOI: 10.1007/s00108-015-3804-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
113
|
Nakagiri T, Knöfel AK, Ius F, Salman J, Sommer W, Avsar M, Jansson K, Pauksch L, Preissler G, Hatz R, Kühn C, Tudorache I, Welte T, Gottlieb J, Haverich A, Warnecke G. Early Survival after Lung Transplantation Is Better in Patients with Higher Frequencies of Regulatory T Cells. Thorac Cardiovasc Surg 2016. [DOI: 10.1055/s-0036-1571753] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
114
|
Ius F, Sommer W, Verboom M, Erdfelder C, Tudorache I, Kühn C, Avsar M, Siemeni T, Salman J, Greer M, Hallensleben M, Blasczyk R, Schwerk N, Gottlieb J, Welte T, Haverich A, Warnecke G. IgM Enriched Human Intravenous Immunoglobulins Based Treatment of Patients with Early Donor Specific Anti-HLA Antibodies after Lung Transplantation. Thorac Cardiovasc Surg 2016. [DOI: 10.1055/s-0036-1571688] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
115
|
Kolditz M, Ewig S, Klapdor B, Schütte H, Winning J, Rupp J, Suttorp N, Welte T, Rohde G. Die ambulant erworbene Pneumonie als akuter Notfall: Prädiktoren des frühen ungünstigen klinischen Verlaufs. Pneumologie 2016. [DOI: 10.1055/s-0035-1570306] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
116
|
Solé-Lleonart C, Roberts JA, Chastre J, Poulakou G, Palmer LB, Blot S, Felton T, Bassetti M, Luyt CE, Pereira JM, Riera J, Welte T, Qiu H, Rouby JJ, Rello J. Global survey on nebulization of antimicrobial agents in mechanically ventilated patients: a call for international guidelines. Clin Microbiol Infect 2015; 22:359-364. [PMID: 26723563 DOI: 10.1016/j.cmi.2015.12.016] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2015] [Revised: 11/26/2015] [Accepted: 12/12/2015] [Indexed: 01/07/2023]
Abstract
Nebulized antimicrobial agents are increasingly administered for treatment of respiratory infections in mechanically ventilated (MV) patients. A structured online questionnaire assessing the indications, dosages and recent patterns of use for nebulized antimicrobial agents in MV patients was developed. The questionnaire was distributed worldwide and completed by 192 intensive care units. The most common indications for using nebulized antimicrobial agent were ventilator-associated tracheobronchitis (VAT; 58/87), ventilator-associated pneumonia (VAP; 56/87) and management of multidrug-resistant, Gram-negative (67/87) bacilli in the respiratory tract. The most common prescribed nebulized agents were colistin methanesulfonate and sulfate (36/87, 41.3% and 24/87, 27.5%), tobramycin (32/87, 36.7%) and amikacin (23/87, 26.4%). Colistin methanesulfonate, amikacin and tobramycin daily doses for VAP were significantly higher than for VAT (p < 0.05). Combination of parenteral and nebulized antibiotics occurred in 50 (86%) of 58 prescriptions for VAP and 36 (64.2%) of 56 of prescriptions for VAT. The use of nebulized antimicrobial agents in MV patients is common. There is marked heterogeneity in clinical practice, with significantly different in use between patients with VAP and VAT. Randomized controlled clinical trials and international guidance on indications, dosing and antibiotic combinations to improve clinical outcomes are urgently required.
Collapse
|
117
|
Schmidt K, Damm K, Prenzler A, Golpon H, Welte T. Preferences of lung cancer patients for treatment and decision-making: a systematic literature review. Eur J Cancer Care (Engl) 2015; 25:580-91. [PMID: 26676876 DOI: 10.1111/ecc.12425] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/11/2015] [Indexed: 11/28/2022]
Abstract
The consideration of patient preferences in decision-making has become more important, especially for life-threatening diseases such as lung cancer. This paper aims to identify the preferences of lung cancer patients with regard to their treatment and involvement in the decision-making process. We conducted a systematic literature review from 12 electronic databases and included studies published between 2000 and 2012. A total of 20 studies were included in this review. These revealed that lung cancer patients do have preferences that should be considered in treatment decisions; however, these preferences are not homogenous. We found that patients often consider life extension to be more important than the health-related quality of life or undesirable side effects. This preference seems to depend on patient age. Nausea and vomiting are the most important side effects to be avoided; the relevance of other side effects differs highly between subgroups. The majority of lung cancer patients, nevertheless, seem to prefer a passive rather than an active role in decision-making, although the self-reported preferences differed partly from the physicians' perceptions. Overall, we identified an urgent need for larger studies that are suitable for subgroup analyses and incorporate multi-attributive measurement techniques.
Collapse
|
118
|
Fätkenheuer G, Kwetkat A, Pletz MW, Schelling J, Schulz RJ, van der Linden M, Welte T. [Prevention in the elderly: position paper on pneumococcal vaccinations. Results of an expert workshop on 15 November 2013 in Cologne, Germany]. Z Gerontol Geriatr 2015; 47:302-9. [PMID: 24850498 DOI: 10.1007/s00391-014-0650-9] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
Infections due to pneumococci especially in the elderly are vastly underestimated, e.g., because non-invasive infections such as pneumonia may appear with only few symptoms. Sequential vaccination with the pneumococcal conjugate vaccine PCV13, followed by the 23-valent polysaccharide vaccine, is considered as the best preventive measure for individual protection, even though clinical study data demonstrating the efficacy of this sequence are not yet available. Increase of "awareness" by use of computer-based reminder functions may result in a significant improvement of vaccination compliance.
Collapse
|
119
|
Pletz M, Ewig S, Heppner H, Welte T. Stellungnahme zur Empfehlung der Pneumokokken-Impfung für Erwachsene. Pneumologie 2015; 69:633-7. [DOI: 10.1055/s-0034-1393413] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
120
|
Salzberger B, Welte T. [Antimicrobial resistance]. Internist (Berl) 2015; 56:1231-2. [PMID: 26507817 DOI: 10.1007/s00108-015-3709-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
121
|
Manuel O, López‐Medrano F, Kaiser L, Welte T, Carratalà J, Cordero E, Hirsch HH. Influenza and other respiratory virus infections in solid organ transplant recipients. Clin Microbiol Infect 2015; 20 Suppl 7:102-8. [PMID: 26451405 PMCID: PMC7129960 DOI: 10.1111/1469-0691.12595] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [MESH Headings] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
|
122
|
Fleischmann C, Hartmann M, Hartog CS, Welte T, Heublein S, Thomas-Rueddel D, Dennler U, Reinhart K. Epidemiology of Sepsis in Germany: Incidence, Mortality And Associated Costs of Care 2007-2013. Intensive Care Med Exp 2015. [PMCID: PMC4798029 DOI: 10.1186/2197-425x-3-s1-a50] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
123
|
Schellong S, Welte T. Dyspnoe. Internist (Berl) 2015. [DOI: 10.1007/s00108-015-3685-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
124
|
Kolditz M, Ewig S, Schütte H, Suttorp N, Welte T, Rohde G. Assessment of oxygenation and comorbidities improves outcome prediction in patients with community-acquired pneumonia with a low CRB-65 score. J Intern Med 2015; 278:193-202. [PMID: 25597400 DOI: 10.1111/joim.12349] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
BACKGROUND Addition of assessment of comorbid diseases ('D') and oxygen saturation ('S') to the CRB-65 score has been recommended to improve its accuracy for risk stratification in community-acquired pneumonia (CAP). The aim of this study was to validate the resulting DS-CRB-65 score in a large cohort of patients with CAP. METHODS A total of 4432 patients prospectively enrolled in the CAPNETZ cohort were included in this study. Predefined end points were 28-day mortality, requirement for mechanical ventilation or vasopressors (MV/VS) and requirement for MV/VS or intensive care unit admission (MV/VS/ICU). Receiver operating characteristic curve analysis was used to determine the accuracy of the CRB-65 score and the addition of D (extra-pulmonary comorbidities) and S (oxygen saturation <90% or partial pressure of oxygen <8 kPa). Binary logistic regression and the method of Hanley and McNeil were used to compare the criteria. RESULTS The mortality rate was 4.0%, and 4.2% of patients required MV/VS and 6.6% required MV/VS/ICU. After multivariate analysis, D and S independently were added to the CRB-65 criteria for mortality prediction, but only S improved prediction of MV/VS and MV/VS/ICU (P < 0.001 for all). The area under the curve of the CRB-65 score was significantly improved by adding D and S for all end points (P < 0.02). Amongst patients who died or required MV/VS despite a CRB-65 score of 0, 64-80% would have been identified by the DS-CRB-65 score. CONCLUSIONS The addition of assessment of oxygenation and comorbidities significantly improved the prognostic accuracy of the CRB-65 score. Consequently, the DS-CRB-65 score may have a useful role in risk stratification algorithms for CAP.
Collapse
|
125
|
Singpiel A, Schneider J, Maus R, Bohling J, Behler-Janbeck F, Stripecke R, Welte T, Maus UA. Transduction efficacy of bone marrow-derived versus pulmonary macrophages in mice with either lentiviral or adenoviral vectors encoding for GM-CSF. Pneumologie 2015. [DOI: 10.1055/s-0035-1556627] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|